Charles Theuer, President and CEO at Tracon Pharmaceuticals, Inc. (TCON), bought 6,800 shares at $1.62 ($11K) on 2023-01-18, disclosed to the SEC on 2023-01-19.
Seasonal purchase ($11k) by President and CEO — this insider has traded TCON in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| TCON | BUY | 2022-12-15 | $30K | — | Filing → |
| TCON | BUY | 2022-11-22 | $20K | — | Filing → |
| TCON | BUY | 2022-11-04 | $14K | — | Filing → |